Shared Reading for Pediatric Ophthalmic Education

May 12, 2026 updated by: Hsin-Ming Liu, Mackay Memorial Hospital

Generative AI-Mediated Shared Reading for Pediatric Ophthalmic Education

We use generative AI to make personalized books for young children about going to the eye doctor. We want to see if reading these stories helps kids feel more comfortable and improves their overall experience at the clinic.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Taiwan
      • Taipei, Taiwan, Taiwan, 10449
        • Mackay Memorial Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Children aged 3 to 5 years.
  • Parents or legal guardians capable of participating in parent-child shared reading (proficient in Traditional Chinese).
  • Agreement to the administration of cycloplegic agents.

Exclusion Criteria:

  • Parents or legal guardians who are not proficient in Traditional Chinese or are unwilling to participate in parent-child shared reading.
  • Children aged under 3 years or 6 years and older.
  • Refusal of cycloplegic agent administration.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Leaflet
Standard printed educational leaflet
Standard printed educational leaflet for cycloplegic refraction exam.
Active Comparator: Book
Commercially available children's book (Maisy Goes to the Eye Doctor) for parent-child shared reading
Maisy Goes to the Eye Doctor
Experimental: Customized book
Customized educational book on cycloplegic drops and refraction procedures, designed via generative AI, also for parent-child shared reading
Generative AI-customized educational book focusing on cycloplegic administration and optometric examination.
Other Names:
  • Maisy Goes to the Eye Doctor
  • Standard printed educational leaflet

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
visual analogue scale of anxiety
Time Frame: 1. Baseline, pre-intervention 2. 30 minutes after the intervention
Pediatric anxiety levels will be quantified using a 0-10 scale supplemented by facial icons. Participants will be shown the scale and asked to select the face or number that best matches how they feel at that moment. The scale is anchored by "No anxiety" (0, happy face) and "Extreme anxiety" (10, distressed face). Research assistants will provide a standardized prompt: "Point to the face that shows how you feel right now."
1. Baseline, pre-intervention 2. 30 minutes after the intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
children's emotional manifestation scale (CEMS)
Time Frame: 30 minutes after the intervention
This observational instrument consists of five behavioral categories: facial expression, vocalization, activity, interaction, and cooperation. Each category is scored on a 5-point Likert scale (1 to 5), with a total score ranging from 5 to 25. Higher scores represent higher levels of emotional distress and negative behaviors.
30 minutes after the intervention
Parent Satisfaction Scale
Time Frame: 30 minutes after the intervention

The Parent Satisfaction Scale is a 10-item self-report questionnaire designed to evaluate the caregiver's perception of the quality of pediatric ophthalmic care. The scale assesses several key domains of the clinical encounter, including patient-centered communication, emotional support, clinician-parent partnership, and overall service quality.

Scoring and Administration:

Each item is scored using a 5-point Likert scale, with response options ranging from 1 (Strongly Disagree) to 5 (Strongly Agree). A total satisfaction score is calculated by summing the responses, with higher scores (ranging from 10 to 50) indicating higher levels of parental satisfaction with the healthcare delivery and the educational intervention provided.

30 minutes after the intervention
Staff Satisfaction Scale
Time Frame: 30 minutes after the intervention

The Staff Satisfaction Scale is a 7-item clinician-reported instrument designed to evaluate the clinical feasibility and perceived quality of a pediatric eye examination. The scale measures the nurse's observation of patient cooperation, parental engagement, and the effectiveness of the clinical workflow.

Scoring and Administration:

Following the patient's encounter, the attending ophthalmic nurse rates each statement using a 5-point Likert scale, ranging from 1 (Strongly Disagree) to 5 (Strongly Agree). Higher aggregate scores indicate a more efficient clinical process and a higher level of professional satisfaction with the care delivery.

30 minutes after the intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

May 26, 2026

Primary Completion (Estimated)

October 26, 2026

Study Completion (Estimated)

October 31, 2026

Study Registration Dates

First Submitted

May 7, 2026

First Submitted That Met QC Criteria

May 12, 2026

First Posted (Actual)

May 15, 2026

Study Record Updates

Last Update Posted (Actual)

May 15, 2026

Last Update Submitted That Met QC Criteria

May 12, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 26MMHIS067e

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Vision Screening

Clinical Trials on standard printed educational leaflet

Subscribe